WO2002076408A2 - Verwendung von kreatin, kreatinin und/oder deren derivaten - Google Patents

Verwendung von kreatin, kreatinin und/oder deren derivaten Download PDF

Info

Publication number
WO2002076408A2
WO2002076408A2 PCT/EP2002/002839 EP0202839W WO02076408A2 WO 2002076408 A2 WO2002076408 A2 WO 2002076408A2 EP 0202839 W EP0202839 W EP 0202839W WO 02076408 A2 WO02076408 A2 WO 02076408A2
Authority
WO
WIPO (PCT)
Prior art keywords
use according
creatine
keratin fibers
weight
hair
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2002/002839
Other languages
German (de)
English (en)
French (fr)
Other versions
WO2002076408A3 (de
WO2002076408A8 (de
Inventor
Rudolf Bimczok
Thomas Kripp
Beate Grasser
Christian Springob
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Deutschland GmbH
Original Assignee
Wella GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7678906&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2002076408(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to AT02722218T priority Critical patent/ATE308303T1/de
Application filed by Wella GmbH filed Critical Wella GmbH
Priority to ES02722218.1T priority patent/ES2250640T5/es
Priority to DE50204766T priority patent/DE50204766D1/de
Priority to BRPI0204506A priority patent/BRPI0204506B8/pt
Priority to AU2002253126A priority patent/AU2002253126A1/en
Priority to JP2002574924A priority patent/JP3590628B2/ja
Priority to EP02722218.1A priority patent/EP1328242B2/de
Priority to US10/363,620 priority patent/US7687055B2/en
Publication of WO2002076408A2 publication Critical patent/WO2002076408A2/de
Publication of WO2002076408A3 publication Critical patent/WO2002076408A3/de
Publication of WO2002076408A8 publication Critical patent/WO2002076408A8/de
Anticipated expiration legal-status Critical
Priority to US11/839,633 priority patent/US8318676B2/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/04Preparations for permanent waving or straightening the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/06Preparations for styling the hair, e.g. by temporary shaping or colouring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/10Preparations for permanently dyeing the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/12Preparations containing hair conditioners

Definitions

  • the present invention relates to the use of an agent comprising creatine, creatinine and / or their derivatives for hardening, improving gloss, strengthening and improving structure (restructuring) or for increasing the volume of keratin fibers, in particular damaged keratin fibers such as damaged human hair.
  • Such influences are particularly noticeable on keratin fibers, especially on human hair, due to a lack of shine, reduced tear strength and poor combability. They are caused by aging processes that are primarily physiological or induced by physical (weathering), mechanical (combing, brushing) and chemical influences. With longer hair, these influences are particularly noticeable in the tips of the hair.
  • the chemical influences include bleaching, oxidative dyeing and permanent waving of the hair, whereby aggressive oxidizing or reducing agents are preferably used in a strongly alkaline environment and show their full effect there. But others too Chemical influences have damaging effects on material containing keratin, for example water enriched with chlorine or salts.
  • DE-A 198 41 385 discloses the use of creatine and creatine derivatives as humectants for cosmetic preparations.
  • the preparations are said to improve the elastic properties of the skin and to help smooth wrinkles and remove cracks and dandruff.
  • the object on which the present invention is based was to provide a composition, in particular a cosmetic hair treatment composition, for use to improve the condition of the hair, which eliminates the aforementioned disadvantages.
  • this object is achieved by the use of an agent comprising creatine, creatinine and / or their derivatives and / or their salts for hardening, strengthening, restructuring, repairing or stabilizing keratin fibers or for increasing the luster, volume or combability of keratin fibers.
  • an agent comprising creatine, creatinine and / or their derivatives and / or their salts for hardening, strengthening, restructuring, repairing or stabilizing keratin fibers or for increasing the luster, volume or combability of keratin fibers.
  • the use according to the invention can also have advantageous effects in the case of conditions or changes in the structure of keratin fibers caused by physiological processes; for example with age-related brittle hair or fine hair, which can be congenital or acquired depending on the age (baby hair, old hair).
  • the present invention thus relates to the use according to claim 1.
  • creatine N-amidinosarcosine
  • creatinine (2-imino-1-methylimidazolidin-4-one)
  • formula II is physiological constituents of human and animal tissue.
  • Other particularly preferably used substances are creatine phosphate, cyclocreatine, phosphocyclocreatine, guadinine acetate, 3-guadinine propionic acid, guadinine ascorbate and creatine pyruvate.
  • Creatine, creatinine and / or their derivatives of the formulas (IU) (IV) or (V) are preferably used according to the invention
  • Ri and R 2 are independently H, -CH 3, -CH 2 CH 3 or linear or branched C 3 to C 8 alkyl, and particularly 'is preferably H, -CH 3, -CH 2 CH 3 or - CH 2 CH 2 CH 3 .
  • the creatine, the creatinine and / or their derivatives and / or their salts is used by bringing the keratin fibers into contact with an agent containing the creatine, the creatinine and / or their derivatives and / or their salts, and this is preferably left there after application or after a suitable exposure time is removed or removed with an aqueous agent is rinsed out. It is preferred if the creatine, the creatinine and / or their derivatives and / or their salts in an amount of 0.001 to 30.0 percent by weight, preferably 0.01 to 10.0 percent by weight, particularly preferably 0.05 to 1.0 Percentage by weight, based in each case on the total amount of the agent, in which agent is contained.
  • the agent described for the use according to the invention can be present in all suitable formulations which are known in the cosmetic or pharmaceutical industry.
  • the agent can be present as an aqueous or aqueous-alcoholic solution, as a gel, cream, emulsion or foam, it being possible for the agent to be formulated both in the form of a one-component preparation and in the form of a multicomponent preparation.
  • the agent contains creatine, creatinine and / or at least one derivative and / or salts thereof together with suitable auxiliaries and carriers (for example thickeners, acids, fragrances, solvents, salts, wetting agents and / or UV absorbers).
  • a first component can either contain the creatine, creatinine and / or at least one derivative and / or salts thereof (active ingredient) on which the present invention is based, or the active ingredient can be used together with an auxiliary (for example a thickener), advantageously in solid dry form (for example as powder in compressed or non-compressed form, as granules or tablets), mixed in this first component.
  • a second or further component contains only auxiliaries and carriers.
  • the use of a composition is characterized which is characterized in that it is present as a one-component preparation or as a multi-component preparation.
  • the agent used is in the form of a multi-component preparation, it comprises a first component which contains the creatine, creatinine and / or their derivatives and / or their salts with or without auxiliaries and additives and a second component which contains the other constituents .
  • the agent used can also be present as a multicomponent preparation with at least three different components, at least one of the components containing creatine, creatinine and / or their derivatives and / or their salts and the other components containing the remaining constituents.
  • the agent used according to the invention can additionally include carriers and auxiliaries, such as, for example, solvents such as water, lower aliphatic alcohols, for example ethanol, n-propanol and isopropanol, glycol ethers or glycols such as glycerol and in particular 1,2-propanediol; Furthermore, solubilizers, wetting agents or emulsifiers from the classes of anionic, cationic, amphoteric or nonionic surface-active substances, such as fatty alcohol sulfates, ethoxylated fatty alcohol sulfates, alkyl sulfonates, alkylbenzenesulfonates, alkyltrimethylammonium salts, alkylbetaines, ethoxylated fatty alcohols, fatty alcohol alcohols, fatty alcohol ethoxylates, ethoxylated fatty alcohols, fatty alcohol alcohols, , ethoxylated fatty acid esters, also thicken
  • Buffer substances such as ammonium hydrogen carbonate; Thiol, ketocarbon acids (oxocarboxylic acids), in particular ⁇ -keto carboxylic acids, or their physiologically compatible salts, UV absorbers, perfumes, dyes, conditioners, hair swelling agents, preservatives, petroleum jelly, paraffin oil and fatty acids as well as care substances such as cationic resins, lanolin derivatives, cholesterol , Pantothenic acid and betaine; Propellants such as B. propane, butane, dimethyl ether, N 2 0 and carbon dioxide.
  • the abovementioned constituents are used in the amounts customary for such purposes, for example water in an amount of 0.1 to 95% by weight, the wetting agents and emulsifiers in a total amount of 0.2 to 30% by weight, the alcohols in an amount from a total of 0.1 to 50 percent by weight, the opacifiers, perfume oils, preservatives and dyes in an amount of 0.01 to 5 percent by weight, the buffer substances in a total amount of 0.1 to 10 percent by weight, solubilizers, stabilizers, and hair conditioning and hair care ingredients in an amount of 0.1 to 5 percent by weight each, while the thickening agents and solubilizers can be contained in a total amount of 0.5 to 20 percent by weight in this agent.
  • the pH of the agent is preferably 2.0 to 10.0, in particular 3.0 to 9.0.
  • the desired pH can be adjusted by adding acids, for example hydroxycarboxylic acids such as lactic acid, tartaric acid, citric acid or malic acid, phosphoric acid, acetic acid, glycolic acid, salicylic acid, glutathione or gluconic acid lactone, or alkalizing agents such as ammonia, alkanolamines, alkylamines, alkali metal hydroxides. Ammonium hydroxides, alkali carbonates, ammonium carbonates or alkali phosphates can be adjusted.
  • the agent can remain there (for example in the hair) or can be rinsed out after use.
  • the exposure time of the agent depending on the temperature (about 20 to 60 degrees Celsius, preferably 30 to 50 degrees Celsius), 1 to 60 minutes, in particular 5 to 20 minutes, the repair effect (hardening, restructuring) tur mich and, if necessary, the associated increase in volume) can be accelerated; therefore the use of heat is preferred.
  • the hair can be rinsed with water and, if necessary, washed with a shampoo.
  • the formulations of the agent suitable for the use according to the invention are preferably shampoos, rinses, cures, foams, setting agents, hair gels, hair sprays, hair colors, hair tints, permanent waving agents, fixings, hair straightening agents or brilliants.
  • the agent can also be used as a pretreatment agent before chemical and / or physical treatments of keratin fibers, in particular hair coloring, hair tinting, hair bleaching or before permanent hair shaping, in order to prevent hair damage from these oxidative treatments.
  • the tensile strength of hair which is an indicator of the structural integrity of the hair cortex and thus a measure of the degree of damage, is determined by means of tension-elongation measurements customary for these purposes. 20 individual hairs are selected from each strand of hair and the individual hair diameters are determined using a computer-controlled laser micrometer. Subsequently, the force required to measure the force is measured using a tensile strain gauge (MTT 160/600 Series Miniature Tensile Tester, Serial No. 600.95.05.001, DIA-STRON Ltd., England). to tear individual hairs apart.
  • MTT 160/600 Series Miniature Tensile Tester Serial No. 600.95.05.001, DIA-STRON Ltd., England
  • bundle tensile strength (BZF) is determined from these individual tensile strength measured values, which differ from one another due to the different hair diameters, by calculating the tensile strength for a hair diameter of 0.08 mm (average diameter), taking into account the respective hair diameter.
  • the hair density is finally converted into the unit of bundle tensile strength (cN / tex). The greater the numerical value of the bundle tensile strength, the less the hair damage.
  • the difference between the mean values given above is statistically highly significant (significance level determined with the t-test: 99.9%).
  • the bundle tensile strength is increased from 14.8 cN / tex to 15.5 cN / tex by the content of 1% by weight creatine; this corresponds to an increase of 4.7%.
  • the combability of the hair is also an important parameter for describing the hair quality.
  • Various external influences such as certain cosmetic treatments (bleaching, dyeing, perms), ventilation, frequent combing and brushing make the hair more difficult to comb, which is due to damage to the cuticle.
  • the principle of most methods for measuring the combability is to measure the force (combing force) required to comb a comb through a strand of hair under precisely defined boundary conditions.
  • Damaged hair (bleached) was treated with the shampoo according to Example 2 but without creatine (the amount of creatine was replaced by water): the combing power was 1.43 +/- 0.05 N (measured mean value from 3 strands of hair treated with shampoo) , Damaged hair (bleached) treated with shampoo according to Example 2 with 1% by weight creatine:
  • the combing force was 1.21 +/- 0.08 N (measured average of 3 strands of hair treated with shampoo).
  • the combing force is reduced by the content of 1% by weight creatine from 1.43 N to 1.21 N, that is to say by 15.3%.
  • the addition of creatine thus results in a clearly detectable improvement in the combability of the hair.
  • Tris (oligooxyethyl) alkyl ammonium phosphate 1.5% by weight

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PCT/EP2002/002839 2001-03-24 2002-03-14 Verwendung von kreatin, kreatinin und/oder deren derivaten Ceased WO2002076408A2 (de)

Priority Applications (9)

Application Number Priority Date Filing Date Title
EP02722218.1A EP1328242B2 (de) 2001-03-24 2002-03-14 Nicht-therapeutische verwendung von kreatin, kreatinin und/oder deren derivaten zur stärkung und verbesserung der haarstruktur
JP2002574924A JP3590628B2 (ja) 2001-03-24 2002-03-14 ケラチン繊維の強化および構造改善に対するクレアチン、クレアチニンおよび/あるいはこれらの誘導体を含有する薬剤の使用
ES02722218.1T ES2250640T5 (es) 2001-03-24 2002-03-14 Uso no terapéutico de creatina, creatinina y/o ciclocreatina para reforzar y mejorar la estructura del cabello
DE50204766T DE50204766D1 (de) 2001-03-24 2002-03-14 Verwendung von kreatin, kreatinin und/oder cyclokreatin zur stärkung und verbesserung der haarstruktur
BRPI0204506A BRPI0204506B8 (pt) 2001-03-24 2002-03-14 aplicação de creatina, creatinina e/ou seus sais
AU2002253126A AU2002253126A1 (en) 2001-03-24 2002-03-14 Use of creatine, creatinine and/or derivatives thereof
US10/363,620 US7687055B2 (en) 2001-03-24 2002-03-14 Method of treating keratinic fibers with creatine, creatinine and/or their salts to strengthen, restructure, harden and stabilize them
AT02722218T ATE308303T1 (de) 2001-03-24 2002-03-14 Verwendung von kreatin, kreatinin und/oder cyclokreatin zur stärkung und verbesserung der haarstruktur
US11/839,633 US8318676B2 (en) 2001-03-24 2007-08-16 Use of agents containing creatine, creatinine and/or their derivatives to fortify and improve the structure of keratinic fibers

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10114561A DE10114561A1 (de) 2001-03-24 2001-03-24 Verwendung von Mitteln enthaltend Kreatin, Kreatin und/oder deren Derivaten zur Verstärkung und Strukturverbesserung von keratinischen Fasern
DE10114561.6 2001-03-24

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10363620 A-371-Of-International 2002-03-14
US11/839,633 Division US8318676B2 (en) 2001-03-24 2007-08-16 Use of agents containing creatine, creatinine and/or their derivatives to fortify and improve the structure of keratinic fibers

Publications (3)

Publication Number Publication Date
WO2002076408A2 true WO2002076408A2 (de) 2002-10-03
WO2002076408A3 WO2002076408A3 (de) 2003-04-10
WO2002076408A8 WO2002076408A8 (de) 2003-05-08

Family

ID=7678906

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/002839 Ceased WO2002076408A2 (de) 2001-03-24 2002-03-14 Verwendung von kreatin, kreatinin und/oder deren derivaten

Country Status (10)

Country Link
US (2) US7687055B2 (enExample)
EP (1) EP1328242B2 (enExample)
JP (1) JP3590628B2 (enExample)
AT (1) ATE308303T1 (enExample)
AU (1) AU2002253126A1 (enExample)
BR (1) BRPI0204506B8 (enExample)
DE (2) DE10114561A1 (enExample)
ES (1) ES2250640T5 (enExample)
RU (1) RU2252010C2 (enExample)
WO (1) WO2002076408A2 (enExample)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003011241A1 (de) * 2001-07-25 2003-02-13 Beiersdorf Ag Verwendung von kreatinin und/oder kreatininderivaten in kosmetischen oder dermatologischen zubereitungen
WO2003011242A1 (de) * 2001-07-25 2003-02-13 Beiersdorf Ag Kosmetische oder dermatologische zubereitungen mit einer kombination von kreatinin und/oder kreatininderivaten mit kreatin und/oder seinen derivaten
WO2004089326A1 (de) * 2003-04-10 2004-10-21 Beiersdorf Ag Kosmetische oder dermatologische zubereitungen mit einer kombination von kreatinin mit kreatin und biochinonen
EP1535603A1 (de) * 2003-11-26 2005-06-01 Beiersdorf AG Kosmetische und dermatologische Zubereitung, enthaltend Kreatin und/oder Kreatinin und Elektrolytkonzentrationen mit einer Ionenstärke von mindestens 50 mmol/l
DE10355716A1 (de) * 2003-11-26 2005-06-23 Beiersdorf Ag Kosmetische Zubereitungen mit einem Gehalt Kreatin und/oder Kreatinderivaten und/oder Kreatinin und/oderKreatininderivaten und organischen Verdickern
DE10355714A1 (de) * 2003-11-26 2005-06-30 Beiersdorf Ag Wirkstoffkombination aus Kreatin und/oder Kreatinin, Phenoxyethanol und gewünschtenfalls Glycerin
EP2140857A1 (de) 2008-07-03 2010-01-06 Beiersdorf AG Stabilisierung wässrig-alkoholischer Formeln durch Menthol

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004218468B2 (en) 2003-02-28 2007-04-19 E-L Management Corp. Method for increasing hair growth
DE10352470A1 (de) * 2003-11-07 2005-06-23 Beiersdorf Ag Polymere Haarfixierungsmittel mit verbesserten Eigenschaften
DE102005004704A1 (de) 2005-02-02 2006-08-10 Goldschmidt Gmbh Guanidinogruppen-haltige Siloxane und deren Verwendung für kosmetische Formulierungen
US8263053B2 (en) * 2005-11-22 2012-09-11 Access Business Group International Hair treatment compositions
EP1813262A1 (en) * 2006-01-19 2007-08-01 Wella Aktiengesellschaft Stable oil-in-water and water/oil/water multiple emulsions and hair treating compositions comprising them
CN101578508B (zh) * 2006-10-24 2013-07-17 沃伊斯亚吉公司 用于对语音信号中的过渡帧进行编码的方法和设备
CN105622463B (zh) 2006-12-26 2019-02-22 兰休斯医疗成像公司 用于使心脏神经支配成像的配体
JP5275570B2 (ja) * 2007-01-30 2013-08-28 花王株式会社 毛髪うねり改善剤
US20080210253A1 (en) * 2007-02-05 2008-09-04 Jose Antonio Carballada Hair care composition
US20080187506A1 (en) * 2007-02-05 2008-08-07 Jose Antonio Carballada Hair care composition
US20100028286A1 (en) * 2008-07-31 2010-02-04 Jose Antonio Carballada Method and Composition for Stabilizing Hair Moisture Levels
US7981167B2 (en) * 2008-07-31 2011-07-19 The Procter & Gamble Company Method and composition for maintaining hair dye color
US20100120871A1 (en) * 2008-11-10 2010-05-13 Dawson Jr Thomas Larry Hair care compositions, methods, and articles of commerce that can increase the appearance of thicker and fuller hair
KR101643262B1 (ko) * 2008-11-27 2016-07-27 도레이 카부시키가이샤 실록산 수지 조성물 및 그것을 사용한 터치 패널용 보호막
US20100215707A1 (en) * 2009-02-25 2010-08-26 Mcdonald Thomas Activated creatinine and precursors thereof as antibacterial agents, compositions and products containing such agents and uses thereof
DE102009001788A1 (de) * 2009-03-24 2010-09-30 Henkel Ag & Co. Kgaa Schonendes Bleichmittel
WO2011056330A1 (en) * 2009-11-09 2011-05-12 Avon Products, Inc. Compositions and methods for enhancing eyelashes
BR122020018186B1 (pt) 2010-05-11 2021-07-27 Lantheus Medical Imaging, Inc Uso de agentes de imagiologia para preparação de uma composição para detecção do transportador de norepinefrina (net) e método para a detecção de net
BR122019017259B1 (pt) 2011-09-09 2022-05-10 Lantheus Medical Imaging, Inc Compostos úteis como agentes de imageamento, composições que os compreende, métodos, e uso de agentes de imageamento
EP2570190A1 (en) 2011-09-15 2013-03-20 Braun GmbH Spray nozzle for dispensing a fluid and sprayer comprising such a spray nozzle
US9358197B2 (en) 2012-06-15 2016-06-07 The Procter & Gamble Company Method employing polyols when chemically modifying the internal region of a hair shaft
US9986809B2 (en) 2013-06-28 2018-06-05 The Procter & Gamble Company Aerosol hairspray product comprising a spraying device
DE102013214713A1 (de) * 2013-07-29 2015-01-29 Evonik Industries Ag Formulierungen enthaltend Sphinganin
EP2990796A1 (en) 2014-08-29 2016-03-02 The Procter and Gamble Company Device for testing the properties of hair fibres
CA2987878C (en) 2015-06-01 2020-07-21 The Procter & Gamble Company Aerosol hairspray product comprising a spraying device
RU2747413C1 (ru) * 2020-01-16 2021-05-04 Общество с ограниченной ответственностью "ЮНИКОСМЕТИК" Средство для ухода за волосами
US12128118B2 (en) 2021-07-29 2024-10-29 The Procter & Gamble Company Aerosol dispenser containing a hairspray composition and a nitrogen propellant

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3941534A1 (de) 1988-12-19 1990-06-21 Lion Corp Haarkonditioniermittel
EP0565010A1 (en) 1992-04-10 1993-10-13 Antonio Rizzo Hair dye and hair growth composition
JPH06240579A (ja) 1993-02-15 1994-08-30 Lion Corp ケラチン繊維処理組成物
DE19841385A1 (de) 1998-09-10 2000-03-16 Sueddeutsche Kalkstickstoff Verwendung von Kreatin und/oder Kreatin-derivaten als Feuchthaltemittel in kosmetischen Zubereitungen
WO2000057839A1 (de) 1999-03-25 2000-10-05 Wella Aktiengesellschaft Verwendung von reduzierenden verbindungen zur verstärkung und strukturverbesserung von keratin enthaltenden materialien
WO2001000203A1 (en) 1999-06-25 2001-01-04 Avicena Group, Inc. Use of creatine or creatine compounds for skin preservation

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE348194C (de) 1916-08-20 1922-02-04 Johannes Korselt Dr Verfahren zur Erhoehung der Festigkeit und Elastizitaet von Wolle, Baumwolle und anderen Pflanzenfasern in spinnfaehigem oder versponnenem Zustande, sowie von Kunstseide, Haaren und Federn in gefaerbtem oder ungefaerbtem Zustande
NL128784C (enExample) * 1965-04-15
DE1984135U (de) * 1967-10-07 1968-04-25 Clivia Fa Klischee.
DE2349050C2 (de) * 1973-09-29 1985-06-05 Wella Ag, 6100 Darmstadt Verfahren und Mittel zur Herabsetzung der Wirkstoffkonzentration in kosmetischen Präparaten
US4009254A (en) * 1974-05-06 1977-02-22 Colgate-Palmolive Company Topical compositions
US3957971A (en) * 1974-07-29 1976-05-18 Lever Brothers Company Moisturizing units and moisturizing compositions containing the same
DE2628999C2 (de) * 1976-06-28 1987-03-26 Henkel KGaA, 4000 Düsseldorf Haarfärbemittel
US4303085A (en) * 1977-06-09 1981-12-01 Carson Products Company System and method for hair treatment
AT370721B (de) * 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
DE3138142A1 (de) * 1981-09-25 1983-04-14 Wella Ag, 6100 Darmstadt "verduennungsmittel fuer dauerwellpraeparate und verfahren zur anwendung desselben"
JPS5879913A (ja) 1981-11-09 1983-05-13 Taizo Ayukawa ヘアトニツク組成物
US4551330A (en) * 1983-06-30 1985-11-05 Helene Curtis Industries, Inc. Skin and hair conditioner compositions and conditioning method
LU86368A1 (fr) * 1986-03-24 1987-11-11 Oreal Procede pour preparer et distribuer un produit comprenant au moins deux composants,et dispositif pour sa mise en oeuvre
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
US5243021A (en) * 1991-07-17 1993-09-07 Lever Brothers Company, Division Of Conopco, Inc. Water-dispersible copolymer containing UVA and UVB light-absorbing monomers
FR2718961B1 (fr) * 1994-04-22 1996-06-21 Oreal Compositions pour le lavage et le traitement des cheveux et de la peau à base de céramide et de polymères à groupements cationiques.
FR2725896B1 (fr) * 1994-10-19 1996-11-29 Sederma Sa Nouvelles compositions cosmetiques ou dermopharmaceutiques
US5942478A (en) * 1995-09-19 1999-08-24 Lopes; John A. Microbicidal and sanitizing soap compositions
JP3453021B2 (ja) 1996-01-22 2003-10-06 花王株式会社 毛髪化粧料
FR2755851B1 (fr) 1996-11-15 1998-12-24 Oreal Compositions cosmetiques detergentes et utilisation
DE59800919D1 (de) 1997-05-31 2001-08-02 Wella Ag Haardauerverformungsverfahren mit zunächst höherem und später niedrigerem pH-Wert in der Reduktionsstufe
JP3776211B2 (ja) 1997-07-22 2006-05-17 花王株式会社 毛髪化粧料
US6159485A (en) 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
US6335023B1 (en) 1999-06-30 2002-01-01 Ruey J. Yu Oligosaccharide aldonic acids and their topical use
US20020044913A1 (en) * 2000-02-11 2002-04-18 Hamilton Nathan D. Cosmetics to support skin metabolism
US6432424B1 (en) * 2000-06-29 2002-08-13 Johnson & Johnson Consumer Companies, Inc. Cosmetic compositions containing creatine, carnitine, and/or pyruvic acid
US6649176B1 (en) 2000-06-29 2003-11-18 Johnson & Johnson Consumer Companies, Inc. Compositions containing mineral water
DE10032964B4 (de) * 2000-07-06 2017-10-12 Beiersdorf Ag Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen
DE10106288A1 (de) 2001-02-02 2002-09-05 Coty Bv Revitalisierender Wirkkomplex für die Haut
DE10133198A1 (de) 2001-07-07 2003-01-23 Beiersdorf Ag Kreatin enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
US20040175403A1 (en) * 2003-03-04 2004-09-09 Lukenbach Elvin R. Skin moisturizing composition

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3941534A1 (de) 1988-12-19 1990-06-21 Lion Corp Haarkonditioniermittel
EP0565010A1 (en) 1992-04-10 1993-10-13 Antonio Rizzo Hair dye and hair growth composition
JPH06240579A (ja) 1993-02-15 1994-08-30 Lion Corp ケラチン繊維処理組成物
DE19841385A1 (de) 1998-09-10 2000-03-16 Sueddeutsche Kalkstickstoff Verwendung von Kreatin und/oder Kreatin-derivaten als Feuchthaltemittel in kosmetischen Zubereitungen
WO2000057839A1 (de) 1999-03-25 2000-10-05 Wella Aktiengesellschaft Verwendung von reduzierenden verbindungen zur verstärkung und strukturverbesserung von keratin enthaltenden materialien
WO2001000203A1 (en) 1999-06-25 2001-01-04 Avicena Group, Inc. Use of creatine or creatine compounds for skin preservation

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003011241A1 (de) * 2001-07-25 2003-02-13 Beiersdorf Ag Verwendung von kreatinin und/oder kreatininderivaten in kosmetischen oder dermatologischen zubereitungen
WO2003011242A1 (de) * 2001-07-25 2003-02-13 Beiersdorf Ag Kosmetische oder dermatologische zubereitungen mit einer kombination von kreatinin und/oder kreatininderivaten mit kreatin und/oder seinen derivaten
WO2004089326A1 (de) * 2003-04-10 2004-10-21 Beiersdorf Ag Kosmetische oder dermatologische zubereitungen mit einer kombination von kreatinin mit kreatin und biochinonen
EP1535603A1 (de) * 2003-11-26 2005-06-01 Beiersdorf AG Kosmetische und dermatologische Zubereitung, enthaltend Kreatin und/oder Kreatinin und Elektrolytkonzentrationen mit einer Ionenstärke von mindestens 50 mmol/l
DE10355716A1 (de) * 2003-11-26 2005-06-23 Beiersdorf Ag Kosmetische Zubereitungen mit einem Gehalt Kreatin und/oder Kreatinderivaten und/oder Kreatinin und/oderKreatininderivaten und organischen Verdickern
DE10355714A1 (de) * 2003-11-26 2005-06-30 Beiersdorf Ag Wirkstoffkombination aus Kreatin und/oder Kreatinin, Phenoxyethanol und gewünschtenfalls Glycerin
US10682534B2 (en) 2003-11-26 2020-06-16 Beiersdorf, Ag Cosmetic preparations containing creatine and/or creatinine and organic thickeners
US10888719B2 (en) 2003-11-26 2021-01-12 Beiersdorf Ag Active substance combination of creatine and/or creatinine and phenoxyethanol
EP2140857A1 (de) 2008-07-03 2010-01-06 Beiersdorf AG Stabilisierung wässrig-alkoholischer Formeln durch Menthol
DE102008040105A1 (de) 2008-07-03 2010-01-07 Beiersdorf Ag Stabilisierung wässrig-alkoholischer Formeln durch Menthol

Also Published As

Publication number Publication date
US20070277332A1 (en) 2007-12-06
DE10114561A1 (de) 2002-09-26
BR0204506B1 (pt) 2014-05-13
WO2002076408A3 (de) 2003-04-10
ES2250640T5 (es) 2015-11-03
ES2250640T3 (es) 2006-04-16
US8318676B2 (en) 2012-11-27
BR0204506A (pt) 2003-04-08
BRPI0204506B8 (pt) 2017-04-25
US20040018162A1 (en) 2004-01-29
EP1328242A2 (de) 2003-07-23
WO2002076408A8 (de) 2003-05-08
US7687055B2 (en) 2010-03-30
JP2004525137A (ja) 2004-08-19
AU2002253126A1 (en) 2002-10-08
EP1328242B2 (de) 2015-07-22
DE50204766D1 (de) 2005-12-08
JP3590628B2 (ja) 2004-11-17
RU2252010C2 (ru) 2005-05-20
EP1328242B1 (de) 2005-11-02
ATE308303T1 (de) 2005-11-15

Similar Documents

Publication Publication Date Title
EP1328242B2 (de) Nicht-therapeutische verwendung von kreatin, kreatinin und/oder deren derivaten zur stärkung und verbesserung der haarstruktur
EP0754443A2 (de) Haarbehandlungsmittel sowie Verfahren zu dessen Herstellung
EP1493423B1 (de) Haarbehandlungsmittel und Haarnachbehandlungsmittel zum Schutz vor Schäden durch chemische Behandlung und zur Reparatur bereits geschädigter Haare enthaltend als Wirksubstanz Alkylguanidin-Verbindungen
DE3602746A1 (de) Haarbehandlungsmittel und verfahren zur verbesserung des zustandes der haare
EP1555986A1 (de) Verwendung von nativem zein zur verbesserung des haarzustandes und mittel
DE69327285T2 (de) Verfahren zur Steigerung von Haarglanz und Reparierung von alkalischen Schädigungen des Haares
DE19533211A1 (de) Haarnachbehandlungsmittel
DE19913427A1 (de) Verwendung von reduzierenden Verbindungen zur Verstärkung und Strukturverbesserung von Keratin enthaltenden Materialien
DE2151740A1 (de) Haarkosmetische mittel
EP1047374A1 (de) Mittel und verfahren zur dauerhaften haarverformung
EP1037591A1 (de) Kosmetische mittel enthaltend eine spezielle wirkstoffkombination
EP0648103B1 (de) Haarbehandlungsmittel
EP1727518B1 (de) Verwendung von mitteln zur kosmetischen behandlung von menschlichen haaren
DE212020000757U1 (de) Haarpflegezusammensetzung
EP0605503B1 (de) Zubereitungen zur haarbehandlung
EP0895468A1 (de) Festes mittel zur behandlung keratinischer fasern
DE4216667C2 (de) Verwendung von alpha-Ketodicarbonsäuren gegen Wasserstoffperoxidreste im Haar
EP0337130A2 (de) Vorrichtung zur Haarbehandlung
DE10244281A1 (de) Verwendung von Kreatin und/oder Kreatin-Derivaten in kosmetischen Haarbehandlungsmitteln
EP1021164A2 (de) Kosmetische mittel
EP0742709B1 (de) Wirkstoffkomplex für haarbehandlungsmittel
DE19711294C1 (de) Haarbehandlungsmittel
EP1032356A1 (de) Splissregenerierende haarbehandlungsmittel
DE19716497C1 (de) Verfahren zur dauerhaften Verformung von menschlichen Haaren
DE102004024505A1 (de) Cystin-basiertes Polykondensat

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2002722218

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref country code: JP

Ref document number: 2002 574924

Kind code of ref document: A

Format of ref document f/p: F

WR Later publication of a revised version of an international search report
WWP Wipo information: published in national office

Ref document number: 2002722218

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10363620

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2002722218

Country of ref document: EP